Please assess the completion status of the following clinical trial:

Trial Title: A Phase 2 Study of BTA798 in Asthmatic Adults With Symptomatic Human Rhinovirus Infection

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male and female subjects aged 18-70 years~* Diagnosis of asthma consistent with Global Initiative for Asthma (GINA) steps 1 to 3~* Presumptive human rhinovirus infection~Exclusion Criteria:~* Current severe asthma exacerbation~* Severe asthma, GINA steps 4 or higher~* Uncontrolled or clinically significant medical condition, disease or event which could impact subject safety and/or study evaluations and/or compliance to the protocol~* Current smoker, ex-smoker of \<1 year, or history of smoking \>/=10 pack years.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- BTA798 (Type: EXPERIMENTAL): None
- Placebo (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).